Hand Sanitizer (Pharmacies) - CIS

  • CIS
  • Revenue in the Hand Sanitizer market is projected to reach US$128.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.72%, resulting in a market volume of US$139.80m by 2029.
  • In global comparison, most revenue will be generated in China (US$385.20m in 2024).
  • In relation to total population figures, per person revenues of US$0.53 are generated in 2024.

Key regions: Japan, United States, Europe, United Kingdom, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in CIS is experiencing significant growth due to the increasing awareness about hand hygiene and the need for effective sanitation.

Customer preferences:
Customers in CIS are increasingly prioritizing their health and hygiene, leading to a growing demand for hand sanitizers. The convenience and portability of hand sanitizers make them a preferred choice for on-the-go sanitization. Additionally, customers are becoming more conscious about the ingredients used in hand sanitizers, preferring those that are alcohol-based and have moisturizing properties to prevent dryness.

Trends in the market:
One of the key trends in the Hand Sanitizer (Pharmacies) market in CIS is the rising popularity of organic and natural hand sanitizers. Customers are increasingly seeking products that are free from harmful chemicals and are made from natural ingredients. This trend is driven by the growing awareness about the potential adverse effects of synthetic chemicals on health and the environment. Another trend in the market is the increasing demand for hand sanitizers with fragrance options. Customers are looking for hand sanitizers that not only provide effective sanitization but also offer a pleasant scent. This trend is driven by the desire for a refreshing and pleasant sensory experience during hand sanitization.

Local special circumstances:
The Hand Sanitizer (Pharmacies) market in CIS is influenced by the local regulations and guidelines regarding hygiene and sanitation. The government and health authorities in CIS have been actively promoting hand hygiene practices, especially during the COVID-19 pandemic. This has led to a surge in demand for hand sanitizers and increased the market opportunities for pharmacies. Furthermore, the retail landscape in CIS is dominated by pharmacies, making them a key distribution channel for hand sanitizers. Pharmacies have established trust and credibility among customers, who rely on them for their healthcare needs. This gives pharmacies a competitive advantage in the hand sanitizer market.

Underlying macroeconomic factors:
The Hand Sanitizer (Pharmacies) market in CIS is also influenced by macroeconomic factors such as population growth, urbanization, and disposable income levels. The increasing population and urbanization in CIS countries have led to a higher concentration of people in cities, where the demand for hand sanitizers is higher due to the higher risk of exposure to germs and viruses. Additionally, rising disposable income levels in CIS countries have contributed to the growth of the hand sanitizer market. As disposable incomes increase, customers are willing to spend more on personal care and hygiene products, including hand sanitizers. In conclusion, the Hand Sanitizer (Pharmacies) market in CIS is experiencing significant growth due to the increasing awareness about hand hygiene, customer preferences for convenient and effective sanitization, and local regulations promoting hand hygiene practices. The market is characterized by trends such as the demand for organic and natural hand sanitizers and hand sanitizers with fragrance options. Pharmacies play a crucial role in the distribution of hand sanitizers, leveraging their trust and credibility among customers. The market is also influenced by macroeconomic factors such as population growth, urbanization, and disposable income levels, which contribute to the increasing demand for hand sanitizers.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)